CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In sum, we report that CD34+ cells from CP-CML are characterized by a proteomic and phospho-proteomic profile that promotes quiescence through the inhibition of proliferation and the promotion of survival.